Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis'

Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis

0.75

Claim your AMA PRA Category 1 Credits or CNE Contact Hours

This course is available for logged in users only. Please login or register to take the course.

Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Th...

Late-Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid-Lowering Th...

Update on Long-Acting Nebulizers for Guideline-Based Maintenance Treatments for Patients w...